Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes
暂无分享,去创建一个
Björn Olsson | Anders Sundström | Zelmina Lubovac-Pilav | Holger Weishaupt | Sven Nelander | Fredrik J. Swartling | Patrik Johansson | B. Olsson | S. Nelander | Zelmina Lubovac-Pilav | H. Weishaupt | F. Swartling | Anders Sundström | Patrik Johansson | Sven Nelander | Holger Weishaupt
[1] Steven J. M. Jones,et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.
[2] Soumen Khatua,et al. Medulloblastoma development: tumor biology informs treatment decisions. , 2015, CNS oncology.
[3] Hendrik Witt,et al. Medulloblastoma comprises four distinct molecular variants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Terence P. Speed,et al. Correcting gene expression data when neither the unwanted variation nor the factor of interest are observed , 2012, Biostatistics.
[5] Roland Eils,et al. The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.
[6] Hugues Bersini,et al. Batch effect removal methods for microarray gene expression data integration: a survey , 2013, Briefings Bioinform..
[7] Steven J. M. Jones,et al. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma , 2013, Acta Neuropathologica.
[8] Andreas Heider,et al. virtualArray: a R/bioconductor package to merge raw data from different microarray platforms , 2013, BMC Bioinformatics.
[9] E. Levanon,et al. Human housekeeping genes, revisited. , 2013, Trends in genetics : TIG.
[10] Scott L. Pomeroy,et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples , 2011, Acta Neuropathologica.
[11] Marco Giordan,et al. A Two-Stage Procedure for the Removal of Batch Effects in Microarray Studies , 2013, Statistics in Biosciences.
[12] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas , 2012, Acta Neuropathologica.
[13] E. Levanon,et al. Human housekeeping genes are compact. , 2003, Trends in genetics : TIG.
[14] Johann A. Gagnon-Bartsch,et al. Using control genes to correct for unwanted variation in microarray data. , 2012, Biostatistics.
[15] Scott Pomeroy,et al. The evolution of medulloblastoma therapy to personalized medicine , 2017, F1000Research.
[16] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[17] Chunyu Liu,et al. Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods , 2011, PloS one.
[18] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[19] Nathan C. Sheffield,et al. Predicting cell-type–specific gene expression from regions of open chromatin , 2012, Genome research.
[20] Gary D Bader,et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma , 2014, Nature.
[21] Andrew E. Jaffe,et al. Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .
[22] Alexander A. Morgan,et al. Multiplex Meta-Analysis of Medulloblastoma Expression Studies with External Controls , 2014, Pacific Symposium on Biocomputing.
[23] E. Hovig,et al. Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses , 2015, Biostatistics.
[24] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[25] Paul A. Northcott,et al. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies , 2013, Acta Neuropathologica.
[26] Sirintra Nakjang,et al. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study , 2017, The Lancet. Oncology.
[27] David T. W. Jones,et al. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts , 2014, Acta Neuropathologica.
[28] Jeffrey T. Leek,et al. Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction , 2014, Bioinform..
[29] A. Goldenberg,et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. , 2017, Cancer cell.
[30] A. Barabasi,et al. Interactome Networks and Human Disease , 2011, Cell.
[31] C. Nordborg,et al. MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes , 2015, Clinical Epigenetics.
[32] Elaine R. Mardis,et al. Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.
[33] Yufeng Liu,et al. R/DWD: distance-weighted discrimination for classification, visualization and batch adjustment , 2012, Bioinform..
[34] Marzieh Vali,et al. Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas , 2014, Clinical Cancer Research.
[35] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.
[36] David T. W. Jones,et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing , 2014, Nature.